News
For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...
Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...
Erectile dysfunction and anti-anxiety medication were among the most common illegal pharmaceuticals seized by Interpol in a ...
15h
Verywell Health on MSN5 Serious Ozempic Side Effects Most People Do Not Know AboutOzempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...
Gov. Jeff Landry vetoes a plan to cover costly weight-loss drugs for Louisiana state workers and teachers, citing long-term ...
12h
The Print on MSNIn battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on otherIndia's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...
14h
Verywell Health on MSNHow Long Does Ozempic Stay in Your System?How long does Ozempic stay in your system? What to expect after stopping, including clearance time, side effects, and factors that influence it.
Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug on the market.
Uninsured or self-pay obesity patients can get any dose of Wegovy for $299 from July 1–31, 2025. Patients can get their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results